Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
NCT01466270
Anxiety Disorder, Anxiety Disorders
View Trial DetailsNCT Number: NCT01264562
The study will investigate the impact of cancer-related stress and its consequences (acute and posttraumatic stress symptoms, altered cortisol secretion) on cognitive function in breast cancer patients. The hypothesis that stress associated with the cancer diagnosis and the cancer treatment is a major cause of cognitive dysfunction in breast cancer patients shall be evaluated.
Looking for future studies?
Notify Me18 year–65 year
Female
Observational
Frauenklinik des Helios Amper Klinikums Dachau, Dachau, Bavaria, Germany
Primary hypothesis:
*The adverse effects of cancer and cancer therapy on cognitive function in breast cancer patients are entirely or partly mediated by stress and the ensuing dysfunction of the HPA-axis.
Secondary objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
, both patient groups:
Inclusion criteria
, healthy control group:
Exclusion criteria
Time frame: 12 months
Performance on a battery of cognitive tests
Time frame: 12 months
Self-reported cognitive problems
Time frame: 12 months
Cortisol awakening response and diurnal profile
Time frame: 12 months
Acute stress response, posttraumatic stress disorder, and posttraumatic stress symptoms; cancer-specific stress
Ludwig-Maximilians - University of Munich
Other
Acronym: Cognicares
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01466270
Anxiety Disorder, Anxiety Disorders
View Trial DetailsNCT00186212
Behavior, Behavioral Symptoms
Stanford, California, United States
View Trial DetailsNCT00186511
Behavior, Behavioral Symptoms
Stanford, California, United States
View Trial DetailsNCT02290834
Breast Cancer, Breast Diseases
Boston, Massachusetts, United States
View Trial Details